KNI-102
KNI-102 is a potent anti-HIV agent with an IC50 value of 100 nM for HIV protease[1].
Product Specifications
CAS Number
139694-65-8
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/kni-102.html
Solubility
10 mM in DMSO
Smiles
O=C(N(CCC1)[C@@H]1C(NC(C)(C)C)=O)[C@@H](O)[C@@H](NC([C@H](CC(N)=O)NC(OCC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3
Molecular Formula
C31H41N5O7
Molecular Weight
595.69
References & Citations
[1]Mimoto T, et al. KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic. Chem Pharm Bull (Tokyo) . 1991 Nov;39 (11) :3088-90.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740808-100 1x 100 µL
TRP1 (Tyrosinase Related Protein 1) (TA99 + TYRP1/807), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682228-500 1x 500 µL
MAPK14 (CPTC-MAPK14-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 